Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: dutton: we are raising our price target to $0.90 per share
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The present Q ends Feb 29.. Results will not be released until April...So if PTSC desires, they could bury this Qs MMP licenses until then... as well as any J2+ settlement numbers...